Manas AI

Colombia Founded: 2025 • Age: 1 yrs
Manas AI is focused on transforming drug development with AI.

About Manas AI

Manas AI is a Healthcare company based in Colombia founded in 2025 by Siddhartha Mukherjee and Reid Hoffman. Manas AI is focused on transforming drug development with AI. It operates on a AI-as-a-Service and HealthTech model. Manas AI has raised $50.6 million across 2 funding rounds from investors including General Catalyst, Reid Hoffman and Greylock Partners. Its chief executive, as recorded, is Siddhartha Mukherjee. Its website manasai.co draws about 34 thousand monthly visits. Manas AI offers products and services including AI-Driven Drug Development Platform and Therapeutic Modalities Development. Its focus areas include Biotechnology and Drug Discovery.

Company details

Manas AI is dedicated to revolutionizing drug development by integrating advanced AI technologies with deep scientific expertise in biology, chemistry, and medicine. The company is engaged in creating foundational neuro-symbolic models to enhance the clinical pipeline from target identification to clinical trials. Solutions are provided across multiple therapeutic modalities, including antibodies and small molecules, supported by a global clinical trial ecosystem. The approach is augmented by human expertise to ensure efficiency and safety in delivering life-saving therapies.

  • Headquarters Colombia
  • Founders Siddhartha Mukherjee, Reid Hoffman
  • Sectors
    Healthcare
  • Website category Finance · Investing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website manasai.co
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $50.6M (USD)

    in 2 rounds

  • Latest Funding Round
    $26M (USD), Seed

    Sep 2025

  • Investors

Products & Services of Manas AI

Manas AI offers a comprehensive portfolio of products and services, including AI-Driven Drug Development Platform and Therapeutic Modalities Development.

AI-Driven Drug Development Platform
Healthcare Technology

Platform for accelerating drug development using AI technology.

Therapeutic Modalities Development
Biotechnology

Supports development across various therapeutic modalities using AI.

Funding Insights of Manas AI

Manas AI has successfully raised a total of $50.6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $26 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $50.6M
  • Total Rounds 2
  • Last Round Seed β€” $26M
  • First Round $24.6M

    (Jan 2025)

  • Investors Count 8

All 2 funding rounds of Manas AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$26MSeed––
Jan 2025$24.6MSeed–General Catalyst, Reid Hoffman
Valuation history

8 investors in total: 7 institutional and 1 angel.

Investors in Manas AI

Manas AI has secured backing from 8 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include General Catalyst, Reid Hoffman and Greylock Partners.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investment and transformation services for entrepreneurs in technology and finance sectors.
generalcatalyst.com
Venture capital firm specializing in early-stage tech investments and founder support.
1965greylock.com
Venture capital firm early-stage investments
thegp.comSan Francisco, United States
Startups are funded by Wisdom Ventures, a venture capital firm.
wisdomventuresfund.comSan Francisco, United States
Venture capital investments are made in tech-enabled startups by Westbound.
westboundequity.com
Early-stage investments in European sectors are managed by Mosaic Ventures.
mosaicventures.comLondon, United Kingdom
blitzscalingvc.com

Reid Hoffman

Co-founder of LinkedIn, venture capitalist, and influential angel investor.
unknown_8de8842f9b2f4bf99
Premium access

Investor details for Manas AI

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Manas AI

2 people are tracked at Manas AI (2 in leadership).

NameRoleGroup
Siddhartha Mukherjee
Co-Founder & CEOLeadership
Reid Hoffman
Co-FounderLeadership
Premium access

Complete people profiles for Manas AI

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Manas AI

3 dated milestones of Manas AI, from founding to its latest funding, stage changes and deals.

  1. Founded Manas AI is founded.
  2. Funding First funding round of $24.6M.
  3. Funding Latest funding round, Seed, of $26.0M.

Web traffic of Manas AI

The website of Manas AI (manasai.co) receives about 34.4K visits a month and ranks #968,500 among all websites worldwide, #8,773 in Investing.

  • Monthly visits
    34.4K

    ▲ 29.8% vs previous month

  • Unique visitors
    14.8K

    per month

  • Global rank
    #968,500

    among all websites

  • Category rank
    #8,773

    Finance · Investing

Similar websites

Websites whose visitors overlap most with Manas AI. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pymnts.com
100%
#85,245View details
manas.ai
79%
5.9K#3,405,435View details
manas.org.in
manas.org.in
57%
#3,580,598–
ncbmanas.gov.in
ncbmanas.gov.in
56%
#2,195,532–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Manas Ai

Manas AI’s $24.6 Million Fundraise
Globallegalchronicle β€’ 1 year ago
Premium access

Complete news archive for Manas AI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manas AI

Manas AI was founded in 2025.

Manas AI is headquartered in Colombia.

Siddhartha Mukherjee is the CEO of Manas AI, as recorded in our data. They have also founded this company.

Manas AI is a funded company, having raised a total of $50.6M across 2 funding rounds to date. The company's 1st funding round was a Seed of $24.6M, raised on Jan 2025.

Manas AI is dedicated to revolutionizing drug development by integrating advanced AI technologies with deep scientific expertise in biology, chemistry, and medicine. The company is engaged in creating foundational neuro-symbolic models to enhance the clinical pipeline from target identification to clinical trials. Solutions are provided across multiple therapeutic modalities, including antibodies and small molecules, supported by a global clinical trial ecosystem. The approach is augmented by human expertise to ensure efficiency and safety in delivering life-saving therapies.

Manas AI offers AI-Driven Drug Development Platform and Therapeutic Modalities Development.

Manas AI has 8 investors. Key investors include General Catalyst, Reid Hoffman, Greylock Partners, The General Partnership, and Wisdom Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available